Live Breaking News & Updates on Otolaryngo

Stay updated with breaking news from Otolaryngo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves New Drug for Generalized Myasthenia Gravis

Zilucoplan is the first once-daily, subcutaneous, self-administered, targeted C5 complement inhibitor for adults with gMG who are AChR antibody positive. ....

United States , Mjamesf Howard , Samantha Masterson , Drug Administration , European Union , Myasthenia Gravis Foundation Of America , Lancet Neurology , North Carolina , Chapel Hill School , Medscape Medical , Myasthenia Gravis Foundation , Muscular Atrophy , Uscular Atrophies , Myasthenia Gravis , Upper Respiratory Infection , Chronic Disease , Chronic Illness , Us Food And Drug Administration , Nited States Food And Drug Administration , Monoclonal Antibody , Neuromuscular Diseases , Respiratory Tract , Self Administration , Tyrosine Kinase ,

Desperate Long COVID Patients Turn to Unproven Therapies

With few evidence-based treatments for long COVID, patients with debilitating symptoms can be tempted by unproven options. ....

New York , United States , Maya Mcnulty , Steven Flanagan , Andrew Schamess , Tai Chi , Yufang Lin , Kathleen Bell , National Center , Census Bureau , Mount Sinai School Of Medicine , Recovery Program , Ohio State Wexner Medical Center , Brookings Institution , University Of Texas Southwestern Medical Center , Department Of Physical Medicine , Snake Oil , Do Salt Rooms Really Offer Health , Resource Center , Health Statistics , Scientific Reports , Physical Medicine , Texas Southwestern Medical Center , Cayman Islands Based , Cleveland Clinic , Infectious Diseases Diagnosis ,